Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
about
Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.Emerging concepts in liquid biopsiesThe Role of Next-Generation Sequencing in Castration-Resistant Prostate Cancer Treatment.Liquid biopsies come of age: towards implementation of circulating tumour DNA.Liquid biopsy: a step forward towards precision medicine in urologic malignancies.Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review.Inferring expressed genes by whole-genome sequencing of plasma DNA.The evolution of chemotherapy for the treatment of prostate cancer.Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer.A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Patient monitoring through liquid biopsies using circulating tumor DNA.Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.Patient-derived Interstitial Fluids and Predisposition to Aggressive Sporadic Breast Cancer through Collagen Remodeling and Inactivation of p53.Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.The potential of liquid biopsies for the early detection of cancer.SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survivalRecent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate CancerNeueste technologische Entwicklungen für die Analyse von zirkulierender Tumor-DNA
P2860
Q33579350-F8CFC93B-C15C-44CF-9605-26369F06B209Q36337259-639116FA-FF36-49BF-A62E-6B1DE6DE32A0Q38982680-D1C6BD95-CBE3-49D9-B93F-4A3DDF86EC4DQ39149201-0F487CE5-F2BC-4338-9C4F-F1922BADBEF2Q39243268-8539146C-F421-41F3-84D8-4E454F346237Q39454057-66BA3CD2-63AA-47AA-BFF7-B63642D7CBADQ42774378-10261401-9D83-460B-8467-D9D6A8B1488EQ45943517-1F4AE9DA-4B1D-43A4-B41B-042E5CBED5A6Q46007270-22CE1549-FA75-4094-944D-215F228FA049Q46086455-829FEE3B-88D1-46D3-BCC6-914AA92CF02AQ47214510-3F4E653E-521C-4F2F-BE33-CC176ECFD4F9Q47563363-368C1714-E11D-4912-BC9C-DA23D33F5A40Q47628875-EBBFAEB1-F18D-4936-A086-4D3C35840821Q48178985-46D8E8D2-07EF-4A1D-86A7-19FDAFDA2961Q48194423-D708C284-2F5E-44E3-B096-BDE38FD24974Q48292408-45232456-A19C-4B48-9401-5FA5F0AF6FCAQ52637922-DB99637C-E167-4631-9594-AC8A0103C65CQ52765122-572172B4-0D7D-4A4F-A4E9-1E32CDB2869DQ54474207-44AF38E3-0163-4810-8587-1F8B10473E70Q55269325-8224A132-0813-43A8-8747-A6A134367E91Q57464748-45207747-D56E-4673-ACC4-236DF0DFFC47Q57492447-86C519AB-E85B-4A80-A68B-13E6F5BAF9E2Q57636579-ADC115BC-C768-4FEE-B932-7229E08B0BC6
P2860
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Whole-genome plasma sequencing ...... in metastatic prostate cancer.
@en
type
label
Whole-genome plasma sequencing ...... in metastatic prostate cancer.
@en
prefLabel
Whole-genome plasma sequencing ...... in metastatic prostate cancer.
@en
P2093
P2860
P50
P356
P1476
Whole-genome plasma sequencing ...... in metastatic prostate cancer
@en
P2093
Gerald Webersinke
Herbert Augustin
Ingrid Lafer
Jelena Belic
Jochen B Geigl
Karl Pummer
Katja Fischereder
Martin Pichler
Martina Auer
Ricarda Graf
P2860
P2888
P356
10.1038/NCOMMS12008
P407
P577
2016-06-22T00:00:00Z